The orthopedic biomaterials market is projected to grow at a rate of 9.0% in terms of value, from 2019 to reach USD 26.28 Billion by 2027. The growth of the market may be attributed to the rise in the prevalence of target conditions.
New York, NY -- (SBWIRE) -- 04/15/2021 -- Increasing prevalence of musculoskeletal diseases is one of the significant factors influencing market growth.
Market Size – USD 11.91 billion in 2018, Market Growth - CAGR of 9.0%, Market Trends – Increasing demand for biomaterials in implantable devices
The global Orthopedic Biomaterials Market is expected to reach USD 26.28 Billion by 2027, according to a new report by Reports and Data. Increasing prevalence of musculoskeletal diseases is one of the significant factors influencing market growth. Musculoskeletal diseases were the foremost reason for disability in four of the six WHO (World Health Organization) regions in 2017. In the 2017 study by Global Burden of Disease (GBD), musculoskeletal diseases were the highest contributor to worldwide disability (responsible for 16.0% of all years of life lived with disability), and lower back pain continued to be the single topmost cause of disability. While the occurrence of musculoskeletal diseases varies by diagnosis and age, 20.0%–33.0% of people worldwide live with an agonizing musculoskeletal condition. This disease is responsible for the highest share of lost workplace productivity.
Rise in the geriatric population is one of the significant factors influencing market growth. It has been estimated that by 2050 approximately 16% of the global population will be aged more than 65 years, which is expected to increase fivefold since 1950. Forecasts from the World Health Organization (WHO), United Nations (UN), and the EU commission all indicate aging as a significant challenge for society, which demands concentrated efforts to meet the requirements of the elderly. Heart disease, cancer, and stroke have been the primary chronic conditions that have had the highest impact on the geriatric population, particularly in high-income countries. Thus, the increasing prevalence of diseases in the growing geriatric population is likely to propel the growth of the market in the forecast period.
Key participants include Evonik Industries AG, Zimmer Biomet, Globus Medical, Stryker, DSM Biomedical, Invibio Ltd., CAM Bioceramics BV, DePuy Synthes Inc., Matexel, and Exactech Inc., among others.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2474
Further key findings from the report suggest
- By material type, ceramic & bioactive biomaterials contributed to the largest market share in 2018 and is likely to grow at the rate of 8.8% in the forecast period. The primary benefit of this biomaterial is that it is sturdy and chemically inert. Also, it has high compressive strength necessary for bone implants, and some ceramic materials are biodegradable.
- By application, orthopedic implants accounted for the largest market size in 2018 and is estimated to grow at the rate of 8.6% in the forecast period.
- By end-users, hospitals dominated the market in 2018 and is anticipated to grow at a rate of 8.5% in the period 2019-2027. The factors including well-resourced operating & diagnostic rooms, higher purchasing power, existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.
- North America held the largest market share in 2018 and is likely to grow at a rate of 8.6% in the forecast period. The market dominance of North America is owing to the presence of advanced healthcare facilities and increasing acceptance of new technologies in the region.
To identify the key trends in the industry, click on the link below: @ https://www.reportsanddata.com/report-detail/orthopedic-biomaterials-market
For the purpose of this report, Reports and Data have segmented the global orthopedic biomaterials market on the basis of material type, application, end-users, and region:
Material Type Outlook (Revenue, USD Million; 2016-2027)
Metallic Orthopedic Biomaterials
Ceramic & Bioactive Biomaterials
Polymeric Orthopedic Biomaterials
Composite Orthopedic Biomaterials
Others
Application Outlook (Revenue, USD Million; 2016-2027)
Orthopedic Implants
Joint Reconstruction/Replacement
Orthobiologics
Visco Supplementation
Bio-Resorbable Tissue Fixation
End-Users Outlook (Revenue, USD Million; 2016-2027)
Hospitals
Clinics
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million; 2016-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Request for Customization: @ https://www.reportsanddata.com/request-customization-form/2474
Table of Content:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2027
Chapter 3. Indicative Metrics
Chapter 4. Orthopedic Biomaterials Segmentation & Impact Analysis
4.1. Orthopedic Biomaterials Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.3. Market restraints analysis
4.2.3.1. Stringent regulatory norms
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter's Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
….
Chapter 9. Competitive Landscape
9.1. Market Revenue Share by Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Market positioning
9.5. Strategy Benchmarking
9.6. Vendor Landscape
Chapter 10. Company Profiles
10.1. Evonik Industries AG
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Technology Insights
10.1.4. Strategic Initiatives
10.2. Zimmer Biomet
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Technology Insights
10.2.4. Strategic Initiatives
10.3. Globus Medical
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Technology Insights
10.3.4. Strategic Initiatives
10.4. Stryker
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Technology Insights
10.4.4. Strategic Initiatives
10.5. DSM Biomedical
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Technology Insights
10.5.4. Strategic Initiatives
10.6. Invibio Ltd.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Technology Insights
10.6.4. Strategic Initiatives
Continue….
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
Browse More Reports :
T-Cell Therapy Market Statistics
Virtual Data Room (VDR) Market Size
Cumene Market Share
Access Control Solutions Market Trends
Brown Sugar Market Overview
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com